Author:
Du Yong,Carrio Ignasi,De Vincentis Giuseppe,Fanti Stefano,Ilhan Harun,Mommsen Caroline,Nitzsche Egbert,Sundram Francis,Vogel Wouter,Oyen Wim,Lewington Val
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference15 articles.
1. Bayer AG. Radium-223 dichloride EMA summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002653/WC500156172.pdf . Accessed 12 May 2017.
2. Bayer HealthCare Pharmaceuticals Inc. Radium Ra 223 dichloride FDA prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203971lbl.pdf . Accessed 12 May 2017.
3. Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369:213–23.
4. Bruland ØS, Nilsson S, Fisher DR, Larsen RH. High-linear energy transfer irradiation targeted to skeletal metastases by the α-emitter 223Ra: adjuvant or alternative to conventional modalities? Clin Cancer Res. 2006;12:6250s–7s.
5. Henriksen G, Breistøl K, Bruland ØS, Fodstad Ø, Larsen RH. Significant antitumor effect from bone-seeking, α-particle-emitting 223Ra demonstrated in an experimental skeletal metastases model. Cancer Res. 2002;62:3120–5.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献